Passage Bio (PASG) holder adds 50,055 shares in open-market buy
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lynx1 Master Fund LP, an entity associated with Lynx1 Capital Management LP and Weston Nichols, purchased 50,055 shares of Passage BIO, Inc. common stock in an open-market transaction. The weighted average purchase price was $4.1175 per share, with individual trades between $3.33 and $4.30 per share.
Following this transaction, the entity’s indirect holdings reported for Passage BIO increased to 673,759 shares of common stock. Lynx1 Capital Management LP and Mr. Nichols each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 50,055 shares ($206,101)
Net Buy
1 txn
Insider
Lynx1 Capital Management LP, Nichols Weston
Role
null | null
Bought
50,055 shs ($206K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common stock, $0.0001 par value per share ("Common Stock") | 50,055 | $4.1175 | $206K |
Holdings After Transaction:
Common stock, $0.0001 par value per share ("Common Stock") — 673,759 shares (Indirect, See footnote)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $4.30 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.
Key Figures
Shares purchased: 50,055 shares
Weighted average price: $4.1175 per share
Price range: $3.33–$4.30 per share
+3 more
6 metrics
Shares purchased
50,055 shares
Open-market buy on 2026-06-25
Weighted average price
$4.1175 per share
Purchase of Passage BIO common stock
Price range
$3.33–$4.30 per share
Individual trades within the reported purchase
Shares held after transaction
673,759 shares
Indirect holdings reported following the trade
Transaction code
P (purchase)
Indicates open-market or private transaction
Ownership type
Indirect
Securities held by Lynx1 Master Fund LP
Key Terms
weighted average price, pecuniary interest, beneficial ownership, ten percent owner, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest financial
"except to the extent of his or its pecuniary interest therein, if any."
beneficial ownership regulatory
"disclaims beneficial ownership of the securities to which this filing relates"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
ten percent owner regulatory
""is_ten_percent_owner": 1"
Section 16 regulatory
"for purposes of Section 16 of the Securities and Exchange Act of 1934"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
